|
【参考文献】
1黄挺，陈家棋，冯春茂，等.真菌性角膜炎药物及手术疗效比较.中国实用眼科杂志1997;15(11):651654
2 Feng GZ, Bai J. Study of the early diagnosis and treatment on fungal keratitis. Int J Ophthalmol(Guoji Yanke Zazhi)2008;8(8):16871688
3 Jusoh S, Omar E, Ravichandran M, et al. Fusarium sp in severe eontact lens related fungal keratitis. Int J Ophthalmol(Guoji Yanke Zazhi)2008;8(4):661 669
4 Rosa RH Jr, Miller D, Alfonso EC. The changing spectrum of fungal keratitis in south Florida. Ophthalmology1994;101(6):10051013
5 ODay DM. Selectioh of appropriate antifungal therapy. Cornea1987;6(4):238245
6 Chander J, Sharma A. Prevalence of fungal corneal ulcers in northern India. Infection1994;22(3):207209
7 Dunlop AA, Wright ED, Howlader SA, et al. Suppurative corneal ulceration in Bangladesh. A study of 142 cases examining the microbiological diagnosis, clinical and epidemiological features of bacterial and fungal keratitis. AustN Z J Ophthalmol1994;22(2):105110
8范德彰,蔡松年.真菌性角膜溃疡318例临床分析.中华眼科杂志1981;17(6):321326
9王丽娅,张月琴,王印其,等.中国三地区真菌性角膜病致病菌种的调查.中华眼科杂志2000;36(2):138140
10付怀平,王印其,王俊英.真菌性角膜溃疡32例病理诊断分析.眼科研究1999;17(2):146
11 Ishida N, Brown AC, Rao GN, et al. Recurrent Fusarium keratomycosis a light and elextron microscopic study. Ann Ophthalmol1984;16(4):354356
12王印其,高长凤,赵东卿.角膜真菌病.中国实用眼科杂志1996;14(9):517
13 Kaufman HE, Wood RM. Mycotic keratitis. Am J Ophthalmol1965;59:9931000
14谢立信，史伟云，刘敏,等.改良角膜活检法对真菌性角膜溃疡的临床诊断.眼科新进展1999;19:8991
15惠延年.眼科学.北京:人民卫生出版社2001:83
16陈松，方严，王雁.现代眼科检查方法与进展.北京:中国协和医科大学出版社2000:234
17吴建国，丁进亚，金中秋,等.通用引物PCR方法快速检测兔眼.真菌性角膜溃疡.眼科新进展2003;23(6):421 422
18 Lu H, Guan HJ. Rapid diagnosis of HSK and fungal keratitis using multiplex polymerase chain reaction. Int J Ophthalmol(Guoji Yanke Zazhi)2004;4(4):657660
19宋海珊.凝集素染色法在真菌性角膜溃疡病原菌检查中的作用.中国实用眼科杂志2003;21(4):296298
20谢立信,史伟云,董晓光,等.108例真菌性角膜炎的临床和组织病理学研究.眼科研究1999;17(4):283285
21杨惠英,索继江,陈世平,等.眼部丝状真菌感染13例致病菌分析.国际眼科杂志2003;3(4):125126
22 Malecha MA. Fungal keratitis caused by Scopulariopsis brevicaulis treated successfully with natamycin. Cornea2004;23(2):201203
23 Goldblum D, Rohrer K, Frueh BE, et al. Corneal concentrations following systemic administration of amphotericin B and its lipid preparations in a rabbit model. Ophthalmic Res2004;36:172176
24 Walker S, Tailor SA, Lee M , et al. Amphotericin B in lipid emulsion: stability, compatibility, and in vitroantifungal activity. Antimicrob Agents Chemother1998;42(4):762766
25 Thomas PA.Current perspectives on ophthalmic mycoses. Clin Microbiol Rev2003;16(4):730797
26 Prajna NV, John RK, Nirmalan PK, et al. A randomised clinical trial comparing 2% econazole and 5% natamycin for the treatment of fungal keratitis. Br J Ophthalmol2003;87(10):12351237
27王文华,李树明,任玉新,等.氟康唑治疗真菌性角膜炎的临床探讨.国际眼科杂志2006;6(1):237
28 Yilmaz S, Maden A. Severe fungal keratitis treated with subconjunctival fluconazole. Am J Ophthalmol2005;140(3):454 458
29 Maertens J, Boogaerts M. The place for itraconazole in treatment. J Antimicrob Chemother2005;56(Suppl 1):3338
30 Sponsel W, Chen N, Dang D, et al. Topical voriconazole as anovel treatment for fungal keratitis. Antimicrob Agents Chemother2006;50(1):262268
31 Sponsel WE, Graybill JR, Nevarez HL, et al. Ocular and systemic posaconazole(SCH56592) treatment of invasive Fusarium solani keratitis and endophthalmitis. Br J Ophthalmol2002;86(7):829830
32 Aperis G, Mylonakis E. Newer triazole antifungal agents: pharmacology,spectrum,clinical efficacy and limitations. Expert Opin Investig Drugs2006;15(6):579602
33 Fiscella RG, Moshifar M, Messick CR, et al. Polyhexamethylene biguanide(PHMB) in the treatment of experimental Fusarium keratomycosis. Cornea1997;16(4):447 449
34 Panda A, Ahuja R, Biswas NR, et al. Role of 0.02% polyhexamethylene biguanide and 1% povidone iodine in experimental Aspergillus keratitis. Cornea2003;22(2):138141
35 Rehman MR, Johnson GJ, Husain R, et al. Randomised trial of 0.2% chlorhexidine gluconate and 2.5% natamycin for fungal keratitis in Bangladesh. Br J Ophthalmol1998;82(2):919925
36 Mohan M, Gupta SK, Kalra VK, et al. Topical silver sulphadiazinea new drug for ocular keratomycosis. Br J Ophthalmol1988;72(3):192195
37 Rodero L, Cordoba S, Cahn P, et al. In vitrosusceptibility studies of Cryptococcus neoformans isolated from patients with no clinical response to amphotericin B therapy. J Antimicrob Chemother2000;45(2):239242
38 Ryder NS, Leitner I. Synergistic interaction of terbinafine with triazoles or amphotericin B against Aspergillus species. Med Mycol2001;39(1):9195
39 Sikder AU, Mamun SA, Chowdhury AH,et al. Study of oral itraconazole and terbinafine pulse therapy in onychomycosis. Mymensingh Med J2006;15(1):7180
40 Li RK, Rinaldi MG. In vitroantifungal activity of nikkomycin Z in combination with fluconazole or itraconazole. Antimicrob Agents Chemother1999;43(6):14011405
41 Neely MN, Ghannoum MA. The exciting future of antifungal therapy. Eur J Clin Microbiol Infect Dis2000;19(12):897914
42 Barchiesi F, Schimizzi AM, Caselli F, et al. Interactions between triazoles and amphotericin B against Cryptococcus neoformans. Antimicrob Agents Chemother2000;44(9):24352441
43 Louie A, Liu W, Miller DA, et al. Efficacies of highdose fluconazole plus amphotericin B and highdose fluconazole plus 5fluorocytosine versus amphotericin B, fluconazole ,and 5fluorocytosine monotherapies in treatment of experimental endocarditis,endophthalmitis,and pyelonephritis due to Candida albicans. Antimicrob Agents Chemother1999;43(12):28312840
44 Clancy CJ, Yu YC, Lewin A, et al. Inhibition of RNA synthesis as a therapeutic strategy against Aspergillus and Fusarium:demonstration of in vitrosynergy between rifabutin and amphotericin B. Antimicrob AgentsChemother1998;42(3):509513
45 Nguyen MH, Clancy CJ, Yu YC, et al. Potentiation of antifungal activity of amphotericin B by azithromycin against Aspergillus species. Eur J Clin Microbiol Infect Dis1997;16(11):846848
46 Ross A. Cytochrome P450 3. Clinical significant drug interaction. Aust J Hosp Pharm2000;30:146149
47 Arai R, Sugita T, Nishikawa A. Reassessment of the in vitro synergistic effect of fluconazole with the nonsteroidal antiinflammatory agent ibuprofen against Candida albicans. Mycoses2005;48:38 41
48 Tanure MA, Cohen EJ, Sudesh S, et al. Spectrum of fungal keratitis at Wills Eye Hospital, Philadelphia, Pennsylvania. Cornea2000;19(3):307312
49张明营.球结膜遮盖术治疗重症真菌性溃疡.国际眼科杂志2008;8(7):1491
50罗小玲,徐锦堂,黄菊天,等.新鲜多层羊膜移植治疗深层角膜溃疡的临床探讨.中国实用眼科杂志2003;21(2):112
51陈剑,丁崎,徐锦堂,等.新鲜羊膜移植术治疗早期碱烧伤对角膜新生血管和上皮愈合的影响.中国实用眼科杂志2002;20(3):206
52王荣光,邹留河,董东生.干燥保存角膜片在真菌性角膜溃疡手术治疗中的作用.中华眼科杂志2000;36(1):1820
53刘克菊,王峰.深层板层角膜切除治疗真菌性角膜炎的效果.眼外伤职业眼病杂志2006;28(6):462463
54陈祖基.眼科临床药理学.北京:化学工业出版社2002:123 上一页 [1] [2] [3] |
